Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Hsueh: Control of vascular cell proliferation and migration by PPAR-γ. (0.10 sec) 

Control of vascular cell proliferation and migration by PPAR-γ

- Free from Publisher
WA Hsueh, S Jackson, RE Law - Diabetes Care, 2001 - Am Diabetes Assoc
Compared with nondiabetic subjects, type 2 diabetic individuals are at an
increased risk for coronary artery disease and coronary restenosis after
angioplasty or stenting. Increased proliferation and migration of vascular ...
Cited by 128 - Related articles - All 5 versions

Peroxisome proliferator-activated receptor γ Its role in atherosclerosis and restenosis


R Pakala, SW Rha, PK Kuchulakanti, E … - Cardiovascular Radiation Medicine, 2004 - Elsevier
Atherogenesis consists of a cascade of events involving interactions of
circulating cells and substances within the vascular wall. The first step of
this cascade involves damage to the endothelium caused by traditional ...
Cited by 2 - Related articles - BL Direct - All 9 versions

Vascular protective effects by activation of nuclear receptor PPARγ


S Wakino, RE Law, WA Hsueh - Journal of diabetes and its complications, 2002 - Elsevier
Pharmaceutical interventions targeting proteins that regulate VSMC growth and
movement are promising new approach to treat diabetes-associated cardiovascular
disease. Peroxisome proliferator-activated receptor-γ (PPARγ) is a ligand- ...
Cited by 44 - Related articles - BL Direct - All 7 versions

PPAR [gamma]-Ligands Inhibit Migration Mediated by Multiple Chemoattractants in …


S Goetze, XP Xi, H Kawano, T Gotlibowski, E … - Journal of cardiovascular pharmacology, 1999 - journals.lww.com
The purpose of this study was to determine the effect of the peroxisome
proliferator-activated receptor γ-(PPARγ) ligands troglitazone (TRO),
rosiglitazone (RSG), and 15-deoxy-Δ prostaglandin J2 (15d-PGJ2) on ...
Cited by 179 - Related articles - BL Direct - All 4 versions

Peroxisome proliferator-activated receptor (PPAR)-γ expression in human vascular smooth …


S Benson, J Wu, S Padmanabhan, TW Kurtz, …, 2000 - nature.com
This study was conducted to determine whether cultured human coronary artery and
aorta vascular smooth muscle (VSM) cells express the nuclear transcription
factor peroxisome proliferator-activated receptor- (PPAR ); whether the ...
Cited by 54 - Related articles - All 6 versions

Peroxisome proliferator–activated receptor activators target human endothelial cells to inhibit …

- ahajournals.org
SM Jackson, F Parhami, XP Xi, JA Berliner, … - Arteriosclerosis, Thrombosis, and Vascular Biology, 1999 - Am Heart Assoc
Abstract—An early event in acute and chronic inflammation and associated
diseases such as atherosclerosis and rheumatoid arthritis is the induced
expression of specific adhesion molecules on the surface of endothelial ...
Cited by 324 - Related articles - BL Direct - All 6 versions

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator- …

- ahajournals.org
V Pasceri, HD Wu, JT Willerson, ETH Yeh - Circulation, 2000 - Am Heart Assoc
Methods and Results—We tested the hypothesis that PPAR activators inhibit
vascular cell adhesion molecule (VCAM-1) and intercellular adhesion molecule
(ICAM-1) expression in cultured endothelial cells (evaluated by flow ...
Cited by 462 - Related articles - BL Direct - All 7 versions

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and …

- ahajournals.org
N Marx, U Schonbeck, MA Lazar, P Libby, J … - Circulation Research, 1998 - Am Heart Assoc
Abstract—Migration of vascular smooth muscle cells (VSMCs) plays an important
role in atherogenesis and restenosis after arterial interventions. The
expression of matrix metalloproteinases (MMPs), particularly MMP-9, ...
Cited by 507 - Related articles - All 7 versions

Expression and function of PPAR {gamma} in rat and human vascular smooth muscle cells

- ahajournals.org
RE Law, S Goetze, XP Xi, S Jackson, Y … - Circulation, 2000 - Am Heart Assoc
From the Department of Medicine (REL, SG, X.-PX, SJ, YK, LD, WPM, WAH); the
Division of Endocrinology, Diabetes, and Hypertension (REL, SG, X.-PX, YK, WPM,
WAH); the Division of Cardiology (SJ, LD); and the Department of Pathology ...
Cited by 390 - Related articles - BL Direct - All 5 versions

Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in …

- onlinejacc.org
T Takagi, T Akasaka, A Yamamuro, Y Honda, … - Journal of the American College of Cardiology, 2000 - Elsevier
We studied 62 stented lesions in 52 patients with plasma glucose levels (PG)
≥11.1 mmol/liter at 2 h after 75 g oral glucose load. The study patients were
randomized into two groups: the troglitazone group of 25 patients with 29 ...
Cited by 198 - Related articles - BL Direct - All 12 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google